Polish laboratory diagnostics market expected to be worth PLN 1.4bn in 2012 - January 2010

A range of factors will stimulate the growth of the in vitro (laboratory) diagnostics market in Poland in the next few years. These will include the transformation of healthcare units into companies bound by commercial law, a more extensive choice of health insurance products available in the country, European funds and the need to comply with EU requirements, which should be assured by healthcare facilities in the very near future. As a result, the market will reach a CAGR of almost 10% for the years 2009-2012.
The article is based on the report “In vitro diagnostics market in Poland 2010. Development forecasts for 2010-2012” published by PMR Publications in January 2010.